Apellis Pharmaceuticals (NASDAQ:APLS) Director Sells $713,561.40 in Stock
MarketBeat
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) Director A. Sinclair Dunlop sold 31,092 shares of the firm's stock in a transaction that occurred on Friday, September 19th. The stock was sold at an average price of $22.95, for a total transaction of $713,561.40. Following the sale, the director owned 68,908 shares of the company's stock, valued at approximately $1,581,438.60. This represents a 31.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
NASDAQ:APLS